
Professor Adam Finn, of the Bristol Medical School, provides an insight into an extraordinary year for Bristol’s community of biomedical researchers.
Prior to the COVID-19 pandemic, my laboratory was focused on the impact of vaccinations on respiratory infections in children. But when COVID-19 hit, we were compelled to pause that work, and redirect our efforts. The nature of our research meant it was possible to make that shift rapidly and we weren’t alone: researchers across the University of Bristol were applying their expertise to the emerging pandemic. The University’s COVID-19 Emergency Research group (Bristol UNCOVER) emerged organically and within a month, there were over 100 researchers, from a vast range of disciplines, meeting online each day to pool resources and expertise, and share progress.